COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,870 Articles (22,568 medRxiv, 8,302 bioRxiv)

Most recent first Previous |  Page 2926: Articles 29251-29260  | Next

ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study
Gill, D., Arvanitis, M., Carter, P., Hernandez Cordero, A. I., Jo, B., Karhunen, V., Larsson, S. C., Li, X., Lockhart, S. M., Mason, A. M., Pashos, E., Saha, A., Tan, V., Zuber, V., Bosse, Y., Fahle, S., Hao, K., Jiang, T., Joubert, P., Lunt, A. C., Ouwehand, W. h., Roberts, D. J., Timens, W., van den Berge, M., Watkins, N. A., Battle, A., Butterworth, A. S., Danesh, J., Engelhard, B. E., Peters, J. E., Sin, D., Burgess, S.
10.1101/2020.04.10.20059121 — Posted: 2020-04-14
Pulmonary radiological change of COVID-19 patients with 99mTc-MDP treatment
Yuan, X., Yi, W., Liu, B., Tian, S., Cao, F., Wang, R., Qi, B., Lu, F., Fang, M., Pei, F., Chen, M., Zhang, L., Zhang, Y., Zhang, X., Pan, Z., Zhao, D., Yu, A.
10.1101/2020.04.07.20054767 — Posted: 2020-04-14
Excess cases of influenza suggest an earlier start to the coronavirus epidemic in Spain than official figures tell us: an analysis of primary care electronic medical records from over 6 million people from Catalonia
Coma, E., Mora, N., Prats-Uribe, A., Fina, F., Prieto-Alhambra, D., Medina-Peralta, M.
10.1101/2020.04.09.20056259 — Posted: 2020-04-14
An agent-based epidemic model REINA for COVID-19 to identify destructive policies
Tuomisto, J. T., Yrjölä, J., Kolehmainen, M., Bonsdorff, J., Pekkanen, J., Tikkanen, T.
10.1101/2020.04.09.20047498 — Posted: 2020-04-14 Discussion: Onsite
Comparative Analysis of COVID-19 Transmission Patterns in Three Chinese Regions vs. South Korea,Italy and Iran
He, J., Chen, G., Jiang, Y., Jin, R., He, M., Shortridge, A., Wu, J., Christakos, G.
10.1101/2020.04.09.20053223 — Posted: 2020-04-14
Calcium channel blocker amlodipine besylate is associated with reduced case fatality rate of COVID-19 patients with hypertension
Zhang, L., Sun, Y., Zeng, H.-L., Peng, Y., Jiang, X., Shang, W.-J., Wu, Y., Li, S., Zhang, Y.-L., Yang, L., Chen, H., Jin, R., Liu, W., Li, H., Peng, K., Xiao, G.
10.1101/2020.04.08.20047134 — Posted: 2020-04-14 Discussion: Onsite
COVID-19: Recovering estimates of the infected fatality rate during an ongoing pandemic through partial data
Villa, M., Myers, J. F., Turkheimer, F.
10.1101/2020.04.10.20060764 — Posted: 2020-04-14
A Stratified Model to Quantify the Effects of Containment Policies on the Spread of COVID-19
Bokharaie, V. S.
10.1101/2020.04.10.20060681 — Posted: 2020-04-14
COVID-19 lockdowns cause global air pollution declines with implications for public health risk
Venter, Z. S., Aunan, K., Chowdhury, S., Lelieveld, J.
10.1101/2020.04.10.20060673 — Posted: 2020-04-14
Chaos, Percolation and the Coronavirus Spread: the Italian case
Bonasera, A., Bonasera, G., Zhang, S.
10.1101/2020.04.10.20060616 — Posted: 2020-04-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).